Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Social Anxiety Disorder
NCT02083926Phase 1Completed
- Sponsor
- Yale University
- Start
- Jan 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine in Social Anxiety Disorder (SAD) (2 arms), sponsored by Yale University. Primary endpoints: Visual Analogue Scale for Anxiety at Day 14 and Liebowitz Social Anxiety Scale at Day 14. Started Jan 2015; status: completed.
02
Drugs
ketamine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT02083926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02083926.